Hyfusin Group Holdings Limited (8512.HK)
HKD 0.29
(-4.92%)
HKD 0.29
(-4.92%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -318.4 Million HKD | -171.23% |
| 2022 | -117.39 Million HKD | -62.13% |
| 2021 | -72.4 Million HKD | 5.05% |
| 2020 | -76.25 Million HKD | -477.86% |
| 2019 | 20.18 Million HKD | 194.85% |
| 2018 | -21.27 Million HKD | -189.47% |
| 2017 | 23.78 Million HKD | 25.03% |
| 2016 | 19.02 Million HKD | 26.8% |
| 2015 | 15 Million HKD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -220.02 Million HKD | 0.89% |
| 2024 Q1 | -220.02 Million HKD | 30.9% |
| 2023 Q2 | -67.99 Million HKD | -139.68% |
| 2023 Q1 | 171.35 Million HKD | 245.96% |
| 2023 FY | -318.4 Million HKD | -171.23% |
| 2023 Q4 | -318.4 Million HKD | -327.98% |
| 2023 Q3 | 139.66 Million HKD | 305.41% |
| 2022 Q1 | 138.34 Million HKD | 291.07% |
| 2022 FY | -117.39 Million HKD | -62.13% |
| 2022 Q4 | -117.39 Million HKD | -177.7% |
| 2022 Q3 | 151.09 Million HKD | 377.18% |
| 2022 Q2 | -54.5 Million HKD | -139.4% |
| 2021 Q4 | -72.4 Million HKD | 0.0% |
| 2021 Q2 | -54.25 Million HKD | -150.05% |
| 2021 FY | -72.4 Million HKD | 5.05% |
| 2021 Q1 | 108.39 Million HKD | 242.15% |
| 2020 Q4 | -76.25 Million HKD | 0.0% |
| 2020 Q2 | 15.96 Million HKD | -46.85% |
| 2020 FY | -76.25 Million HKD | -477.86% |
| 2020 Q1 | 30.03 Million HKD | 48.85% |
| 2019 Q1 | 57.58 Million HKD | 370.63% |
| 2019 FY | 20.18 Million HKD | 194.85% |
| 2019 Q4 | 20.18 Million HKD | 0.0% |
| 2019 Q2 | 6.63 Million HKD | -88.48% |
| 2018 Q4 | -21.27 Million HKD | 0.0% |
| 2018 FY | -21.27 Million HKD | -189.47% |
| 2018 Q2 | 32.81 Million HKD | 224.56% |
| 2018 Q1 | 10.1 Million HKD | -57.49% |
| 2017 FY | 23.78 Million HKD | 25.03% |
| 2017 Q1 | 17.45 Million HKD | 0.0% |
| 2017 Q4 | 23.78 Million HKD | 0.0% |
| 2016 FY | 19.02 Million HKD | 26.8% |
| 2015 FY | 15 Million HKD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 27.54 Million HKD | 1256.001% |
| Innovative Pharmaceutical Biotech Limited | 914.37 Million HKD | 134.823% |
| China Overseas Nuoxin International Holdings Limited | 9.99 Million HKD | 3286.958% |
| Prosperous Future Holdings Limited | -337.41 Million HKD | 5.633% |
| Huasheng International Holding Limited | 175.03 Million HKD | 281.91% |
| Fourace Industries Group Holdings Limited | -250.33 Million HKD | -27.194% |
| Evergreen Products Group Limited | 430.83 Million HKD | 173.905% |
| EC Healthcare | 1.05 Billion HKD | 130.323% |
| Ming Fai International Holdings Limited | -329.49 Million HKD | 3.363% |
| Blue Moon Group Holdings Limited | -4.18 Billion HKD | 92.389% |
| SuperRobotics Holdings Limited | 126.44 Million HKD | 351.824% |
| Takbo Group Holdings Limited | -175.44 Million HKD | -81.492% |